# Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF

> **NCT02201914** · PHASE4 · UNKNOWN · sponsor: **Bioroma** · enrollment: 250 (estimated)

## Conditions studied

- Poor Responders
- IVF
- Clomiphene Citrate
- GnRH Agonist
- GnRH Antagonist

## Interventions

- **DRUG:** Clomiphene citrate
- **DRUG:** Daily FSH and LH plus Cetrorelix
- **DRUG:** Triptorelin plus daily FSH anh LH

## Key facts

- **NCT ID:** NCT02201914
- **Lead sponsor:** Bioroma
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2014-10
- **Final completion:** 2014-11
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2014-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02201914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02201914, "Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02201914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*